Characterizing the Dynamic Expression of C1q/TNF-α-Related Protein 6 (CTRP6) during Pregnancy in Humans and Mice with Gestational Diabetes Mellitus

Jianan Jiang,Shuangyu Wei,Miao Chen,Yutian Tan,Zhao Yang,Guiying Yang,Weijie Feng,Zhen Han,Xiaojing Wei,Xiao Luo
DOI: https://doi.org/10.3390/biomedicines12051128
IF: 4.757
2024-05-20
Biomedicines
Abstract:Aim: C1q/TNF-related protein 6 (CTRP6) is a novel adipokine involved in insulin resistance. Thus, we aim to investigate the expression profile of CTRP6 in the plasma, adipose tissue and placenta of GDM patients and mice. Methods: Chinese Han pregnant women (GDM n = 9, control n = 10) with a scheduled caesarean section delivery were recruited. A number of high-fat diet (HFD) induced-pregnancy C57BL/6 mice were chosen as an animal model of GDM. Circulating levels of CTRP6 and adiponectin were examined by ELISA. CTRP6 expression in adipose tissue and placenta were detected by real-time qPCR and WB. Result: Plasma CTRP6 levels were decreased during the first and second trimesters in mice, as well as the second and third trimesters in patients, while they were increased at delivery in GDM patients and mice. Plasma CTRP6 levels were significantly correlated with WBC, systolic pressure, diastolic pressure and fasting blood glucose. Moreover, CTRP6 mRNA expression in the subcutaneous (sWAT) and omental white adipose tissue (oWAT), as well as in the placenta, was significantly higher in GDM human patients at cesarean delivery. Furthermore, the mRNA expression of Ctrp6 was increased in the sWAT and visceral WAT (vWAT), whilst decreased in the interscapular brown adipose tissue (iBAT), of GDM mice at cesarean delivery. Conclusion: Dynamically expressed CTRP6 may be served as a candidate target for treatment of GDM.
biochemistry & molecular biology,medicine, research & experimental,pharmacology & pharmacy
What problem does this paper attempt to address?
This paper aims to explore the dynamic expression characteristics of C1q/TNF - α - related protein 6 (CTRP6) in patients with gestational diabetes mellitus (GDM) and mice. Specifically, the research objectives include: 1. **Evaluate the expression changes of CTRP6 in the plasma, adipose tissue and placenta of GDM patients and mice**: - The researchers measured the plasma CTRP6 levels of Chinese Han GDM patients and normal glucose tolerance (NGT) control group during the second and third trimesters of pregnancy and at delivery. - Further detected the mRNA expression levels of CTRP6 in subcutaneous white adipose tissue (sWAT), visceral white adipose tissue (oWAT) and placenta in these groups. 2. **Analyze the relationship between CTRP6 expression and clinical indicators**: - Explore the correlation between plasma CTRP6 levels and the clinical characteristics of pregnant women and newborns (such as white blood cell count, blood pressure, fasting blood glucose, etc.). 3. **Establish a GDM mouse model to verify the expression changes of CTRP6**: - Using a high - fat diet - induced GDM mouse model, detect its plasma CTRP6 levels at different pregnancy stages and its expression changes in adipose tissue and placenta. Through these studies, the authors hope to reveal the role of CTRP6 in the pathological process of GDM, thereby providing new candidate targets for the treatment of GDM.